 |
|
Julie has a strong
academic and commercial background. With degrees in molecular
biology and medical genetics, Julie went on to complete her
Ph.D. at Oxford University in cardiovascular genetics and
was then appointed a Research Fellow at University College
London.
Before joining Scottish Equity Partners, Julie worked
as an analyst for a US consulting firm, specialising
in cardiovascular disease indication markets and emerging
technology market assessments - experience that gives
her a real understanding of market dynamics and product
positioning.
|
